Literature DB >> 23034938

Zona occludens-2 protects against podocyte dysfunction induced by ADR in mice.

Pablo Bautista-García1, José L Reyes, Dolores Martín, María C Namorado, Bibiana Chavez-Munguía, Elizabeth Soria-Castro, Otmar Huber, Lorenza González-Mariscal.   

Abstract

Zona occludens-2 (ZO-2) is a protein present at the tight junction and nucleus of epithelial cells. ZO-2 represses the transcription of genes regulated by the Wnt/β-catenin pathway. This pathway plays a critical role in podocyte injury and proteinuria. Here, we analyze whether the overexpression of ZO-2 in the glomerulus, by hydrodynamics transfection, prevents podocyte injury mediated by the Wnt/β-catenin pathway in the mouse model of adriamycin (ADR) nephrosis. By immunofluorescence and immunogold electron microscopy, we show that ZO-2 is present in mice glomerulus, not at the slit diaphragms where nephrin concentrates, but in the cytoplasm and at processes of podocytes. Our results indicate that in the glomeruli of mice treated with ADR, ZO-2 overexpression increases the amount of phosphorylated β-catenin, inhibits the expression of the transcription factor snail, prevents nephrin and podocalyxin loss, reduces podocyte effacement and massive fusions, restrains proteinuria, and supports urea and creatinine clearance. These results suggest that ZO-2 could be a new target for the regulation of hyperactive Wnt/β-catenin signaling in proteinuric kidney diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23034938     DOI: 10.1152/ajprenal.00089.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.

Authors:  Junnan Wu; Chunxia Zheng; Yun Fan; Caihong Zeng; Zhaohong Chen; Weisong Qin; Changming Zhang; Wanfen Zhang; Xiao Wang; Xiaodong Zhu; Mingchao Zhang; Ke Zen; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

2.  SUMOylation regulates the intracellular fate of ZO-2.

Authors:  Franziska Wetzel; Sonnhild Mittag; Misael Cano-Cortina; Tobias Wagner; Oliver H Krämer; Rainer Niedenthal; Lorenza Gonzalez-Mariscal; Otmar Huber
Journal:  Cell Mol Life Sci       Date:  2016-09-07       Impact factor: 9.261

3.  TAZ is important for maintenance of the integrity of podocytes.

Authors:  Jianchun Chen; Xiaoyong Wang; Qian He; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-14

4.  MicroRNA-196a/b Mitigate Renal Fibrosis by Targeting TGF-β Receptor 2.

Authors:  Jiao Meng; Limin Li; Yue Zhao; Zhen Zhou; Mingchao Zhang; Donghai Li; Chen-Yu Zhang; Ke Zen; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

5.  Effects of hydrogen sulfide on high glucose-induced glomerular podocyte injury in mice.

Authors:  Ye Liu; Huichen Zhao; Ye Qiang; Guanfang Qian; Shengxia Lu; Jicui Chen; Xiangdong Wang; Qingbo Guan; Yuantao Liu; Yuqin Fu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Zonula occludens 2 and Cell-Cell Contacts Are Required for Normal Nuclear Shape in Epithelia.

Authors:  Christian Hernández-Guzmán; Helios Gallego-Gutiérrez; Bibiana Chávez-Munguía; Dolores Martín-Tapia; Lorenza González-Mariscal
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

Review 7.  Beyond cell-cell adhesion: Emerging roles of the tight junction scaffold ZO-2.

Authors:  Andreas Traweger; Sebastian Toepfer; Roland N Wagner; Josef Zweimueller-Mayer; Renate Gehwolf; Christine Lehner; Herbert Tempfer; Istvan Krizbai; Imola Wilhelm; Hans-Christian Bauer; Hannelore Bauer
Journal:  Tissue Barriers       Date:  2013-04-01

8.  The SGK3-triggered ubiquitin-proteasome degradation of podocalyxin (PC) and ezrin in podocytes was associated with the stability of the PC/ezrin complex.

Authors:  Ya-Pei Yuan; Hong Zhao; Li-Qin Peng; Zi-Fang Li; Song Liu; Cheng-Yan Yuan; Mercy-Julian Mwamunyi; David Pearce; Li-Jun Yao
Journal:  Cell Death Dis       Date:  2018-11-01       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.